Search for: "Harris v. Blockbuster, Inc."
Results 21 - 40
of 42
Sort by Relevance
|
Sort by Date
3 Dec 2013, 7:27 am
In Discount Drug Mart, Inc. v. [read post]
27 Aug 2012, 11:29 am
--Harris v. [read post]
7 Mar 2012, 2:14 am
After the break a brief discussion of: Marmet Health Care Center, Inc. v. [read post]
9 Aug 2011, 10:07 am
Citing to Balsam v. [read post]
12 Jul 2011, 7:47 am
Levine, 555 U.S. 555 (2009), in Pliva, Inc. v. [read post]
28 Mar 2011, 7:02 pm
The criminal case is U.S. v. [read post]
20 May 2010, 3:20 pm
See also, Harris v. [read post]
4 Jan 2010, 4:32 pm
* the contract is illusory because eBay may modify it (see, e.g., the uncited Harris v. [read post]
16 Oct 2009, 4:49 pm
Facebook, Inc.; Justia Page.) [read post]
16 Oct 2009, 3:17 pm
The Texas Class Action (Harris v. [read post]
28 Jul 2009, 3:00 am
Blockbuster, Inc. [read post]
20 Jul 2009, 5:48 am
., Inc. v. [read post]
24 Jun 2009, 3:00 am
In Harris v. [read post]
10 Jun 2009, 11:26 am
By Eric Goldman Harris v. [read post]
16 May 2009, 12:42 pm
Blockbuster Inc., No. 09-217, (N.D. [read post]
23 Apr 2009, 11:00 am
(See Harris v. [read post]
17 Apr 2009, 7:21 am
(The case is Harris v. [read post]
19 Sep 2008, 6:00 pm
: (Spicy IP), India: Supreme Court on exclusive marketing rights: (Spicy IP), Japan: First induced pluripotent stem (iPS) cell patent at Kyoto University: (Competitive Info), Slovenia: Supplementary protection certificates in Slovenia: (The SPC Blog), United States: Biotech/pharma lobbying scoreboard – second quarter update – part II: (Patent Docs), United States: Ferring Pharmaceuticals argues to bring down direct purchaser suits: (Law 360), United States: Transferred… [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
29 Feb 2008, 8:00 am
– Teva’s opposition proceedings regarding IL 130424 to Pfizer: (IP Factor), Thailand: Thai chief drug price negotiator removed from post: (GenericsWeb), Thailand: Compulsory licences cannot be revoked: (Generic Pharmaceuticals & IP), (more from Generic Pharmaceuticals & IP), UK: Court of Appeal for England and Wales hands down decision in Boehringer Ingelheim KG and Boehringer Ingelheim Pharma KG v Swingward Limited relating to repackaging and… [read post]
